Coaching GLP-1 Clients: How to Adapt Your Approach for Ozempic and Wegovy Users
GLP-1 medications — Ozempic, Wegovy, Mounjaro — have reshaped the weight loss landscape. They've also reshaped what personal trainers need to know. More and more clients are arriving at sessions on GLP-1s, and if you don't adapt your approach, you risk letting them lose something they didn't want to lose: their muscle mass.
Here's what trainers need to understand about the physiology of GLP-1 clients, and how to adapt their programming accordingly.
Key Takeaways
- 25-40% of GLP-1 weight loss can be lean muscle mass without proper resistance training intervention
- GLP-1 clients need higher protein targets (1.6-2.2g/kg) and more resistance training frequency
- Side effects (nausea, fatigue) require adjustments to training timing and intensity
- Caloric reduction (30-50%) affects energy availability for training — start with lower volume
- Clear scope: trainers guide exercise, registered dietitians and prescribing physicians handle clinical nutrition
The Muscle Loss Problem on GLP-1s
The clinical trials on GLP-1 medications — the SURMOUNT and STEP series — show total weight loss reaching 15-22% of body weight. That's remarkable. But in these studies, roughly 25-40% of mass lost was lean mass (muscle, bone), not fat.
For a client who loses 15 kg on Wegovy, that can mean 4-6 kg of muscle gone. That's a long-term health problem: muscle mass is tied to longevity, metabolic resilience, and quality of life after 50. The good news: proper resistance training and sufficient protein intake can significantly reduce lean mass loss. The trainer's role becomes critical in the GLP-1 equation.
How to Adapt Programming for a GLP-1 Client
Prioritize resistance training. If your client's program was cardio-focused, the priorities need to shift. Resistance training 2-4 times per week is the most effective intervention for preserving muscle mass during accelerated weight loss. Compound movements — squat, deadlift, press, pull — remain the foundation.
Adjust session timing. GLP-1 clients frequently report nausea in the first hours of the day, especially early in treatment. Schedule sessions late morning or early afternoon where possible, when side effects tend to be less intense. Avoid fasted training.
Reduce initial volume and progress slowly. Appetite and caloric intake are drastically reduced — often by 30-50%. Your client doesn't have the same energy reserves they had before. Start with lower volume than usual, monitor recovery closely, and increase progressively based on tolerance.
Communicate about protein importance. You're not a dietitian — but you can inform clients of the critical role of high protein intake (1.6-2.2g/kg body weight) in preserving muscle. Redirect them to a registered dietitian or their prescribing physician for the detailed nutrition strategy.
Warning Signs and When to Escalate
Some situations require direct communication with the client's prescribing physician:
- Excessive fatigue across more than 2-3 consecutive sessions without improvement
- Unusually rapid strength loss on compound lifts
- Signs of hypoglycemia during exercise (trembling, dizziness, confusion)
- Nausea or vomiting during or after sessions
Your role is to observe physical performance and flag anything unusual to the medical team. Adjusting the medication isn't your call — reporting what you observe is.
An Opportunity for Trainers Who Build This Knowledge
The GLP-1 client market is going to keep growing. In 2025, roughly 9 million Americans were on a GLP-1 medication — a number projected to double by 2027. Ozempic prescriptions in France grew 180% between 2022 and 2024.
Trainers who understand the specific physiology of these clients, can adapt their programming accordingly, and can collaborate with medical teams as GLP-1 use expands will differentiate themselves in a crowded market. This isn't a niche topic anymore — it's a skill set that's becoming table stakes.